Documents
Application Sponsors
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
None (Tentative Approval) | 003 |
Application Products
001 | SOLUTION;INTRAVENOUS | 100MG/4ML (25 mg/mL) | 0 | Pemetrexed | Pemetrexed |
002 | SOLUTION; INJECTION | 500MG/20ML (25MG/ML) | 0 | Pemetrexed | Pemetrexed |
003 | SOLUTION;INTRAVENOUS | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | 1 | PEMETREXED | PEMETREXED DISODIUM |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | TA | 2021-05-06 | STANDARD |
Submissions Property Types
CDER Filings
SANDOZ INC
cder:Array
(
[0] => Array
(
[ApplNo] => 214657
[companyName] => SANDOZ INC
[docInserts] => ["",""]
[products] => [{"drugName":"Pemetrexed","activeIngredients":"Pemetrexed","strength":"100MG\/4ML (25 mg\/mL)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"Pemetrexed","activeIngredients":"Pemetrexed","strength":"500MG\/20ML (25MG\/ML)","dosageForm":"SOLUTION; INJECTION","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"Pemetrexed","activeIngredients":"Pemetrexed","strength":"1000MG\/40ML (25MG\/ML)","dosageForm":"SOLUTION; INJECTION","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"05\/06\/2021","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/214657Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-05-06
)
)